Topic description and stories

We are are helping to end death and disease caused by cancer, saving more lives by detecting early and personalising treatments. The experiences of patients and their families shape every stage of research and of plans for the Cambridge Cancer Research Hospital, as we work together to change the story of cancer.

Professor Jean Abraham speaking to a patient

Cambridge is changing the story of cancer

15 July 2024

Find out about groundbreaking cancer research at Cambridge, including our planned new hospital, how we're studying the earliest stages of cancer, how AI is helping fight the disease, and the patients playing a key role in our work.

Read more

Weight loss condition provides insight into failure of cancer immunotherapies

08 Nov 2016

A weight loss condition that affects patients with cancer has provided clues as to why cancer immunotherapy – a new approach to treating cancer by...

Read more

Self-renewable killer cells could be key to making cancer immunotherapy work

26 Oct 2016

A small molecule that can turn short-lived ‘killer T-cells’ into long-lived, renewable cells that can last in the body for a longer period of time...

Read more

Cambridge extends world leading role for medical imaging with powerful new brain and body scanners

24 Oct 2016

The next generation of imaging technology, newly installed at the University of Cambridge, will give researchers an unprecedented view of the human...

Read more
Accident & Emergency Sign

Diagnosis of cancer as a medical emergency leads to poorer prognosis for many patients

11 Oct 2016

Too many patients – particularly those from disadvantaged backgrounds – are being diagnosed with cancer as medical emergencies, say researchers. This...

Read more

Cambridge Enterprise joins largest early stage investment in a university spin-out

04 Oct 2016

Cambridge spin-out Carrick Therapeutics raises $95 million in funding, representing the largest-ever early stage investment in a UK university spin-...

Read more
Crystal structure of parallel quadruplexes from human telomeric DNA.

Quadruple helix form of DNA may aid in the development of targeted cancer therapies

12 Sep 2016

Researchers have identified the role that a four-stranded version of DNA may play in the role of cancer progression, and suggest that it may be used...

Read more
Image of an oesophageal carcinoma

Oesophageal cancer treatments could be tailor-made for individual patients, study finds

06 Sep 2016

Tailored, targeted treatment for patients with oesophageal cancer could be developed after scientists discovered that the disease can be classified...

Read more

Obesity linked to premature death, with greatest effect in men

14 Jul 2016

A study of 3.9 million adults published today in The Lancet has found that being overweight or obese is associated with an increased risk of...

Read more
Basal cell carcinoma in mouse tail epidermis derived from a single mutant stem cell

Where did it all go wrong? Scientists identify ‘cell of origin’ in skin cancers

08 Jul 2016

Scientists have identified for the first time the ‘cell of origin’ – in other words, the first cell from which the cancer grows – in basal cell...

Read more

A shaggy dog story: The contagious cancer that conquered the world

17 May 2016

A contagious form of cancer that can spread between dogs during mating has highlighted the extent to which dogs accompanied human travellers...

Read more
solidarity against cancer

Study provides clues to why some breast cancers are hard to beat

10 May 2016

Scientists have unearthed crucial new genetic information about how breast cancer develops and the genetic changes which can be linked to survival...

Read more
DNA representation (cropped)

Scientists double number of known genetic risk factors for endometrial cancer

03 May 2016

An international collaboration of researchers has identified five new gene regions that increase a woman’s risk of developing endometrial cancer, one...

Read more

Pages